PNNL

Abstract

Improvements in the ability to obtain detailed in vivo metabolic information have been identified as key elements of better understanding the efficacy and toxicity of new therapies. A new NMR technology called LOCMAT is discussed that yields substantially increased spectral resolution of spatially localized in vivo 1H NMR metabolite spectra, as illustrated by measurements in the liver and heart of a live mouse. Thus, LOCMAT promises to significantly enhance the utility of NMR spectroscopy for biomedical research.